Our objective was to analyse phenotypic and genetic data of extended-spectrum b-lactamase (ESBL)-producing Klebsiella pneumoniae, Enterobacter cloacae, Escherichia coli and Serratia marcescens that cause infections in our hospital. Over a 3 year period, 342 randomly selected clinical Enterobacteriaceae isolates were tested for ESBL production and evaluated for the presence of the b-lactamase genes bla SHV , bla TEM, bla CTX-M and bla TLA-1 . The antibiotic susceptibilities of these isolates were also determined, and the clonality of the isolates was assessed by PFGE. Based on our analyses, 33/92 (35.9 %) K. pneumoniae, 31/87 (35.6 %) Enterobacter cloacae, 24/80 (30 %) E. coli and 17/83 (20.5 %) S. marcescens were identified as ESBL producers. The presence of TEM, SHV or CTX ESBL types was detected in 99/105 (94 %) of the isolates. TLA-1 was not detected in any of the 105 isolates. The dominant ESBL types were bla SHV-5 (n533), bla SHV12 (n531) and bla CTX-M-15 (n530). The predominant ESBL identified in E. coli and Enterobacter cloacae isolates was CTX-M-15, whereas in K. pneumoniae and S. marcescens the predominant types were SHV-12 and SHV-5, respectively. PFGE genotyping revealed two main genetic patterns in the K. pneumoniae isolates, types SHV-12 and TEM-1+SHV-5. An outbreak caused by Enterobacter cloacae SHV-5+CTX-M-15 was detected. In contrast, most ESBL-producing isolates of E. coli and S. marcescens did not have similar PFGE banding patterns and thus were not genetically similar. Enterobacteriaceae are a concern in our hospital, especially K. pneumoniae and Enterobacter cloacae. Our results confirm that the CTX-M-15 ESBL type has spread rapidly in the hospital, and thus requires careful monitoring.
INTRODUCTION
Enterobacteriaceae rendered resistant to penicillins, broadspectrum cephalosporins and monobactams, by the production of extended-spectrum b-lactamases (ESBLs), are recognized as major causes of both nosocomial and community-acquired infections (Bradford, 2001; Cantó n et al., 2008) . ESBLs are found predominantly in Klebsiella species and Escherichia coli, but have been described in other species as well, including Enterobacter, Serratia, Citrobacter, Proteus and Salmonella (Paterson & Bonomo, 2005) .
The prevalence of ESBL-expressing bacteria varies across different geographical regions. Fewer than 10 % of isolated strains express ESBLs in Sweden, Japan and Singapore, compared to rates higher than 30 % in Portugal, Italy, New York and some Latin American countries. In Turkey, as many as 58 % of isolated strains express ESBLs (Paterson & Bonomo, 2005) .
ESBLs arise mainly due to mutations in b-lactamases encoded by the bla SHV , bla TEM, and bla CTX-M genes. At present, more than 300 different ESBL variants have been described (Paterson & Bonomo, 2005) . Though TEM and SHV variants are the most common ESBLs, during the past decade strains expressing CTX-M ESBLs have begun to emerge in many countries (Bonnet, 2004) and are now the most frequent non-TEM, non-SHV ESBL type. CTX-M b-lactamases are characterized by selective hydrolysis of cefotaxime rather than ceftazidime, though some CTX-M types, such as CTX-M-15, may actually hydrolyse ceftazidime (Poirel et al., 2001) . Other ESBL enzymes, such as OXA, VEB, PER and GES, are less frequently encountered (Paterson & Bonomo, 2005) . In Mexico, several studies have reported the high prevalence of SHV-5 (Espinosa de los Monteros et al., 2008; Miranda et al., 2004) . A novel ESBL type, TLA-1 (Silva et al., 2000) , has been associated with SHV-5 (Alcantar-Curiel et al., 2004) . In this report, we present a comprehensive phenotypic and genetic analysis of ESBL-producing infectious Klebsiella pneumoniae, Enterobacter cloacae, E. coli and Serratia marcescens isolated from a tertiary care hospital in Mexico.
METHODS
Clinical isolates. A total of 342 randomly selected K. pneumoniae (n592), E. coli (n580), Enterobacter cloacae (n587) and S. marcescens (n583) isolates were collected from the tertiary-care Hospital Universitario 'Dr José Eleuterio González' in Monterrey, Mexico, from January 2006 to January 2009. Information was collected about the patients from whom strains were isolated, including age, sex and the hospital unit where the patient stayed. Clinical specimens included those from the lower respiratory tract (n5138), wounds (n543), blood (n538), fluids other than cerebrospinal fluid (CSF) and blood (n534), abscesses (n532), catheters (n530), CSF (n59) and urine (n518). Only one isolate per patient was included in our analyses.
Clinical isolates were identified using standard biochemical methods (Murray et al., 2007) . When needed, API 20E galleries were used according to the manufacturer's instructions, and results were interpreted using API 20 E V4.1 identification software. Bacterial isolates were stored in Brucella broth containing 15 % glycerol at -70 uC.
ESBL production and characterization. The ESBL phenotypic detection test was performed using the combination disc method, using ceftazidime, cefotaxime and the inhibitory effect of clavulanic acid recommended by the Clinical and Laboratory Standards Institute (CLSI, 2009) . When an ESBL phenotype was detected, PCR assays were conducted to test isolates for the presence of the bla SHV , bla TEM , bla CTX-M and bla TLA-1 genes. To obtain template DNA, 3-5 colonies from each isolate were boiled in sterile water for 5 min. Samples were centrifuged and 2 ml supernatant was used as the DNA template. The PCRs were carried out using published primers (Berçot et al., 2010; Coque et al., 2002; Siu et al., 1999) . PCR products were purified using the Wizard PCR preps DNA purification system (Promega). All bidirectional nucleotide sequencing was performed at the Instituto de Biotecnología, Universidad Nacional Autó noma de México (Cuernavaca, Morelos, Mexico), using the above PCR primers. Nucleotide sequences and the derived amino acid sequences were compared with previously described sequences (GenBank database http://www.ncbi.nlm.nih.gov/ and www.lahey.org/studies, respectively).
Antibiotic susceptibility testing was performed on all ESBL producers using the broth microdilution method as described by the CLSI (2009). Six b-lactam antibiotics were tested: ceftriaxone, ceftazidime, cefepime, ampicillin, piperacillin and meropenem. Isolates were also tested against non-b-lactam antibiotics, including amikacin, levofloxacin and tigecycline.
PFGE. Isolates were genotyped using PFGE. Genomic DNA from each strain was isolated in an agarose-embedded form and subjected to in-gel enzymic digestion using 50 U XbaI. The agarose plug was subsequently placed in the preformed wells of an agarose gel. PFGE was performed for 23 h with a CHEF Mapper system (Bio-Rad) using 0.56TBE buffer (106TBE: 890 mM Tris-borate, 890 mM boric acid, 20 mM EDTA). PFGE profiles were visualized under UV after staining with ethidium bromide (0.5 mg ml 21 ). Patterns were interpreted using the Tenover criteria (Tenover et al., 1995) .
RESULTS AND DISCUSSION
ESBL production and resistance rates Using the phenotypic assay, 33/92 (35.9 %) of K. pneumoniae, 31/87 (35.6 %) of Enterobacter cloacae, 24/80 (30 %) of E. coli and 17/83 (20.5 %) of S. marcescens were identified as ESBL producers. All of the ESBL producers tested positive for at least one of the b-lactamase encoding genes by PCR. However, ESBLs could be sequenced in only 99 of the 105 isolates. The six other isolates contained bla TEM-1 , which is not an ESBL (Table 1 ). The dominant ESBL types detected were bla SHV-5 (n533), bla SHV12 (n531) and bla CTX-M-15 (n530).
A particularly interesting result was the finding that 66.7 % of the E. coli and 38.7 % of the Enterobacter cloacae isolates contained CTX-M-15. In contrast to other CTX-M types, this ESBL type may hydrolyse ceftazidime (Poirel et al., 2001) . CTX-M-15 has been detected in Salmonella sp. (Rotimi et al., 2008) and is believed to be the dominant ESBL type in some Asian countries (Bonnet, 2004) , occurring in 99.6 % of E. coli and 99.2 % of K. pneumoniae isolates in Thailand (Kiratisin et al., 2008) . The only report of the CTX-M-15 type in Mexico was made recently in E. coli (Rocha-Gracia et al., 2010). Our study confirms that the CTX-M-15 ESBL has spread in Enterobacteriaceae, because it was the most prevalent ESBL in the E. coli and Enterobacter cloacae isolates analysed in this study.
To our knowledge, CTX-M ESBLs are not the predominant type in Mexican hospitals. SHV ESBLs, along with a new ESBL named TLA-1, are more commonly reported in these institutions (Espinosa de los Monteros et al., 2008; GarzaRamos et al., 2009; Silva et al., 2000) . None of the isolates in this study contained TLA-1.
The dominant ESBL in K. pneumoniae was SHV-12 (51.5 %) and in S. marcescens it was SHV-5 (47.1 %). The isolation of S. marcescens SHV-5 is somewhat relevant because it represents a serious threat in the hospital, as was shown by a previous outbreak caused by a cephalosporin-resistant S. marcescens SHV-5 producing strain reported in a Mexican hospital. In this outbreak, the strain was isolated from patients, from medical staff and from chlorhexidine disinfectant solutions (Espinosa de los Monteros et al., 2008) .
High resistance rates were observed for levofloxacin and, as expected, for ampicillin. In contrast, low resistance was observed for amikacin and tigecycline, and none of the strains was resistant to meropenem. The most highly resistant ESBL strains were Enterobacter cloacae SHV-5+CTX-M-15, Enterobacter cloacae TEM-1+CTX-M-15, E. coli TEM-1+CTX-M-15, K. pneumoniae SHV-12 and S. marcescens SHV-12. These strains were more than 50 % resistant to four of the nine antibiotics tested. The high resistance rates observed for these isolates are not surprising, as bacteria that produce CTX-M-type b-lactamases typically have high cefotaxime MICs, of greater than 64 mg ml
21
. In particular, CTX-M-15 may actually hydrolyse ceftazidime, with an MIC as high as 256 mg ml 21 (Baraniak et al., 2002; Poirel et al., 2002) . Additionally, cefepime MICs for the CTX-M ESBL types are greater than those observed for bacteria that produce other ESBL types (Yu et al., 2002) . Furthermore, the SHV-12 type has been associated with high-level resistance to ceftazidime (Tansawai et al., 2009 ).
Molecular epidemiology
The majority of ESBL producers were isolated from lower respiratory tract specimens (n544), followed by catheter (n515), blood (n514), wound (n511), fluids other than CSF and blood (n58), abscesses (n57), urine (n55) and CSF (n52). A pulsotype was defined as a group of isolates that displayed PFGE banding patterns ¢85 % similar (Singh et al., 2006) . Eighty-two pulsotypes could be described from the PFGE patterns of the isolates tested.
Our analyses revealed that 78.3 % (18/23) of the typable K. pneumoniae isolates could be separated into two clones (Fig. 1, Table 2 ). A total of 37 % (10/27) of Enterobacter cloacae isolates could be grouped into two clones, of which one clone (clone 3) was an SHV-5+CTX-M-15 producer. Though SHV-5-producing Enterobacter cloacae strains have been described in Mexico (Garza-Ramos et al., 2009) , this is, to the best of our knowledge, the first report of an Enterobacter cloacae strain isolated in Mexico that produces both SHV-5 and CTX-M15. PFGE analysis revealed a high genomic heterogeneity among ESBL-producing E. coli and S. marcescens isolates. 
Characterization of ESBL-producing Enterobacteriaceae
More than 70 % of these isolates could not be assigned to clonal groups. This is in contrast to published reports that describe a high degree of genetic relatedness among E. coli and S. marcescens strains isolated in other hospitals (Paterson & Bonomo, 2005) .
In this study, we detected six isolates that contained TEM-1, which has been reported in many countries (Al-Obeid et al., 2008; Severin et al., 2010) . However, TEM-1 is not an ESBL, and surveillance of strains carrying the TEM-1 b-lactamase is needed, as these strains may give rise to new ESBL types. Evidence that these strains can develop into new ESBLs was presented after an outbreak of a TEM-1-containing Klebsiella oxytoca strain. After patients were treated with ceftazidime, K. oxytoca TEM-12 was detected in the same neonatal unit (Du Bois et al., 1995) . In our study, TEM-1 was detected in K. pneumoniae, E. coli and Enterobacter cloacae (six isolates in total), which may increase the potential health risk of this non-ESBL type. In these isolates, the presence of other non-common ESBL types, such as OXA, VEB, PER and GES, may be responsible for the ESBL phenotype observed for the isolates characterized in this study, though additional testing to detect the presence of genes encoding the less common ESBL types is needed to confirm this.
In conclusion, K. pneumoniae and Enterobacter cloacae were the species with the highest ESBL production, and multiple CTX-M-15 isolates were detected in this Mexican hospital. The results of this study describe the genetic characteristics and molecular epidemiology of ESBLs among Enterobacteriaceae isolates at a tertiary care hospital in Mexico and provide insight into the emergence of bacterial strains harbouring ESBL genes.
